These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19264476)

  • 1. MDM2 309 T/G polymorphism is associated with lung cancer risk among Asians.
    Gui XH; Qiu LX; Zhang HF; Zhang DP; Zhong WZ; Li J; Xiao YL
    Eur J Cancer; 2009 Jul; 45(11):2023-6. PubMed ID: 19264476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of MDM2 SNP309 variation with lung cancer risk: evidence from 7196 cases and 8456 controls.
    Zhuo W; Zhang L; Zhu B; Ling J; Chen Z
    PLoS One; 2012; 7(7):e41546. PubMed ID: 22844496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cigarette smoking, MDM2 SNP309, gene-environment interactions, and lung cancer risk: a meta-analysis.
    Bai J; Dai J; Yu H; Shen H; Chen F
    J Toxicol Environ Health A; 2009; 72(11-12):677-82. PubMed ID: 19492228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDM2 309 T/G polymorphism is associated with colorectal cancer risk especially in Asians: a meta-analysis.
    Fang F; Yu XJ; Yu L; Yao L
    Med Oncol; 2011 Dec; 28(4):981-5. PubMed ID: 20503107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 309T>G polymorphism and risk of squamous cell carcinomas of head and neck: a meta-analysis.
    Liu J; Zheng Y; Lei D; Liu D; Xu F; Jin T; Cao X; Zhao X; Yu X; Pan X
    Asian Pac J Cancer Prev; 2011; 12(8):1899-903. PubMed ID: 22292622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MDM2 309 T/G polymorphism is associated with head and neck cancer risk especially in nasopharyngeal cancer: a meta-analysis.
    Zhang Y; Bai Y; Zhang Y; Guan J; Chen L
    Onkologie; 2012; 35(11):666-70. PubMed ID: 23147543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MDM2 T309G polymorphism and risk of lung cancer: an updated meta-analysis of 10,186 cases and 14,155 controls.
    Tian X; Wang B; Guo J; Liu X; Zhang T; Liang C; Zhou N; Hou X; Ma Y; Yu H; Chen L; Ren Z; Fan K; Tian Q
    Panminerva Med; 2016 Dec; 58(4):341-348. PubMed ID: 27171940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between murine double minute 2 T309G polymorphism and risk of liver cancer.
    Tang T; Song X; Yang Z; Huang L; Wang W; Tan H
    Tumour Biol; 2014 Nov; 35(11):11353-7. PubMed ID: 25119589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MDM2 SNP309T>G polymorphism increases bladder cancer risk among Caucasians: a meta-analysis.
    Wang HG; Wu QY; Zhou H; Peng XS; Shi MJ; Li JM; Zhou YF
    Asian Pac J Cancer Prev; 2014; 15(13):5277-81. PubMed ID: 25040988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between MDM2 promoter SNP309 T/G polymorphism and liver cancer risk - a meta-analysis.
    Ma HB; Huang T; Han F; Chen WY
    Asian Pac J Cancer Prev; 2012; 13(6):2841-6. PubMed ID: 22938470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis.
    Ding H; Dai Y; Ning Z; Fan N; Wang Z; Li P; Zhang L; Tao Y; Wang H
    Medicine (Baltimore); 2016 Mar; 95(12):e2941. PubMed ID: 27015167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An updated meta-analysis on the association of MDM2 SNP309 polymorphism with colorectal cancer risk.
    Qin X; Peng Q; Tang W; Lao X; Chen Z; Lai H; Deng Y; Mo C; Sui J; Wu J; Zhai L; Yang S; Li S; Zhao J
    PLoS One; 2013; 8(9):e76031. PubMed ID: 24098760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.
    Zhang X; Miao X; Guo Y; Tan W; Zhou Y; Sun T; Wang Y; Lin D
    Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDM2 SNP309 variation contributes to leukemia risk: meta-analyses based on 7259 subjects.
    Zhuo W; Zhang L; Ling J; Zhu B; Chen Z
    Leuk Lymphoma; 2012 Nov; 53(11):2245-52. PubMed ID: 22563815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of MDM2 T309G polymorphism in susceptibility and prognosis of nonsmall cell lung cancer: a meta-analysis.
    Kong Q; Li P; Tian Q; Ha MW
    Genet Test Mol Biomarkers; 2014 May; 18(5):357-65. PubMed ID: 24673452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current evidence on the relationship between SNP309 polymorphism in the MDM2 gene and colorectal cancer risk.
    Fu Q; Zhang G; Chen H; Zheng Y; Cheng J
    Tumour Biol; 2013 Dec; 34(6):3721-9. PubMed ID: 23912932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of MDM2 gene SNP 309 polymorphism and human non-small cell lung cancer susceptibility: A meta-analysis.
    Luan L; Wang H; Zhao B; Wang F; Shi J; Xu X
    Pathol Res Pract; 2019 Sep; 215(9):152538. PubMed ID: 31326197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDM2 SNP309T>G polymorphism with hepatocellular carcinoma risk: a meta-analysis.
    Liu GY; Jiang DK; Shen SQ; Yu L
    Arch Med Res; 2011 Feb; 42(2):149-55. PubMed ID: 21565629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the MDM2 T309G polymorphism and leukemia risk: a meta-analysis.
    Yan YL; Han F; Tan WM; Wu CP; Qin X
    Asian Pac J Cancer Prev; 2014; 15(16):6767-72. PubMed ID: 25169523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MDM2 309T>G polymorphism and ovarian cancer risk: a meta-analysis of 1534 cases and 2211 controls.
    Ma YY; Guan TP; Yao HB; Yu S; Chen LG; Xia YJ; He XJ; Wang HJ; Jiang XT; Tao HQ
    PLoS One; 2013; 8(1):e55019. PubMed ID: 23383041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.